IIM
Ipswich Investment Management Portfolio holdings
AUM
$414M
This Quarter Return
+2.7%
1 Year Return
+15.04%
3 Year Return
+70.41%
5 Year Return
+132.95%
10 Year Return
+315.52%
AUM
$205M
AUM Growth
+$205M
(+1.2%)
Cap. Flow
+$26.2K
Cap. Flow
% of AUM
0.01%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
137
New
3
Increased
28
Reduced
59
Closed
5
Top Buys
| 1 |
Church & Dwight Co
CHD
|
$1.15M |
| 2 |
Truist Financial
TFC
|
$795K |
| 3 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
$474K |
| 4 |
Labcorp
LH
|
$428K |
| 5 |
WEC Energy
WEC
|
$311K |
Top Sells
| 1 |
Wells Fargo
WFC
|
$666K |
| 2 |
CVS Health
CVS
|
$602K |
| 3 |
TE
TECO ENERGY INC
TE
|
$408K |
| 4 |
HSBC
HSBC
|
$263K |
| 5 |
American International
AIG
|
$216K |
Sector Composition
| 1 | Healthcare | 18.54% |
| 2 | Energy | 15.39% |
| 3 | Technology | 12.07% |
| 4 | Industrials | 11.96% |
| 5 | Financials | 11.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Starbucks
SBUX
$100B
| $2.8M | 1.37% |
51,786
+2,790
| +6% | +$151K |
|
27
Marriott International Class A Common Stock
MAR
$72.7B
| $2.8M | 1.37% |
41,628
+800
| +2% | +$53.9K |
|
|
CELG
28
DELISTED
Celgene Corp
CELG
| $2.63M | 1.28% |
25,125
-52
| -0.2% | -$5.44K |
|
29
EOG Resources
EOG
$68.2B
| $2.62M | 1.28% |
27,066
-100
| -0.4% | -$9.67K |
|
30
Colgate-Palmolive
CL
$67.9B
| $2.59M | 1.27% |
34,981
-789
| -2% | -$58.5K |
|
|
31
American International
AIG
$45.1B
| $2.51M | 1.23% |
42,296
-3,634
| -8% | -$216K |
|
32
Gilead Sciences
GILD
$140B
| $2.37M | 1.16% |
30,001
+816
| +3% | +$64.6K |
|
33
Akamai
AKAM
$11.3B
| $2.36M | 1.15% |
44,544
-3,498
| -7% | -$185K |
|
|
34
Church & Dwight Co
CHD
$22.7B
| $2.35M | 1.15% |
49,062
+24,036
| +96% | +$1.15M |
|
35
Duke Energy
DUK
$95.3B
| $2.27M | 1.11% |
28,304
-104
| -0.4% | -$8.32K |
|
36
TJX Companies
TJX
$152B
| $2.26M | 1.1% |
30,175
+245
| +0.8% | +$18.3K |
|
|
37
Labcorp
LH
$23.1B
| $2.24M | 1.1% |
16,297
+3,110
| +24% | +$428K |
|
|
38
CVS Health
CVS
$92.8B
| $2.03M | 0.99% |
22,851
-6,767
| -23% | -$602K |
|
39
Novartis
NVS
$245B
| $1.97M | 0.96% |
24,938
-1,120
| -4% | -$88.4K |
|
|
SIVB
40
DELISTED
SVB Financial Group
SIVB
| $1.93M | 0.94% |
17,460
| – | – |
|
41
AT&T
T
$209B
| $1.84M | 0.9% |
45,346
+250
| +0.6% | +$10.2K |
|
42
JPMorgan Chase
JPM
$829B
| $1.8M | 0.88% |
27,072
| – | – |
|
43
PepsiCo
PEP
$204B
| $1.8M | 0.88% |
16,507
-355
| -2% | -$38.6K |
|
|
44
Truist Financial
TFC
$60.4B
| $1.62M | 0.79% |
42,825
+21,090
| +97% | +$795K |
|
45
Bristol-Myers Squibb
BMY
$96B
| $1.59M | 0.78% |
29,542
-350
| -1% | -$18.9K |
|
46
Verizon
VZ
$186B
| $1.47M | 0.72% |
28,253
+210
| +0.7% | +$10.9K |
|
47
Nike
NKE
$114B
| $1.43M | 0.7% |
27,245
-625
| -2% | -$32.9K |
|
48
Coca-Cola
KO
$297B
| $1.42M | 0.7% |
33,646
| – | – |
|
49
T Rowe Price
TROW
$23.6B
| $1.37M | 0.67% |
20,580
-1,284
| -6% | -$85.4K |
|
50
Thermo Fisher Scientific
TMO
$186B
| $1.34M | 0.65% |
8,390
+875
| +12% | +$139K |
|